Yu-xiang Fang

State Key Laboratory Of Systems Medicine For Cancer
Shanghai, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Elevated Expression of Selenoprotein Synthesis Enzyme SEPHS2 Driven by ATF4 Promotes the Resistance to Ferroptosis in Prostate Cancer.

Elevated Expression of Selenoprotein Synthesis Enzyme SEPHS2 Driven by ATF4 Promotes the Resistance to Ferroptosis in Prostate Cancer.

Journal: MedComm

Published: October 05, 2025

ATOH8 confers the vulnerability of tumor cells to ferroptosis by repressing SCD expression.

ATOH8 confers the vulnerability of tumor cells to ferroptosis by repressing SCD expression.

Journal: Cell death and differentiation

Published: August 03, 2024

Correction: PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5Amediated chromatin accessibility.

Correction: PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5Amediated chromatin accessibility.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 14, 2024

Targeting SOX4/PCK2 signaling suppresses neuroendocrine trans-differentiation of castration-resistant prostate cancer.

Targeting SOX4/PCK2 signaling suppresses neuroendocrine trans-differentiation of castration-resistant prostate cancer.

Journal: Biology direct

Published: April 22, 2024

PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5A-mediated chromatin accessibility.

PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5A-mediated chromatin accessibility.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 23, 2024

Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor-Associated Macrophages in Prostate Cancer.

Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor-Associated Macrophages in Prostate Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 14, 2023

Discovery of extracellular vesicle-delivered miR-185-5p in the plasma of patients as an indicator for advanced adenoma and colorectal cancer.

Discovery of extracellular vesicle-delivered miR-185-5p in the plasma of patients as an indicator for advanced adenoma and colorectal cancer.

Journal: Journal of translational medicine

Published: March 29, 2023

Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.

Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.

Journal: Cancer letters

Published: July 14, 2021

Regulation of Formation, Stemness and Therapeutic Resistance of Cancer Stem Cells.

Regulation of Formation, Stemness and Therapeutic Resistance of Cancer Stem Cells.

Journal: Frontiers in cell and developmental biology

Published: December 14, 2020

Discovery of extracellular vesicles derived miR-181a-5p in patient's serum as an indicator for bone-metastatic prostate cancer.

Discovery of extracellular vesicles derived miR-181a-5p in patient's serum as an indicator for bone-metastatic prostate cancer.

Journal: Theranostics

Published: June 07, 2020

Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex.

Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 12, 2018

Loss of Par3 promotes prostatic tumorigenesis by enhancing cell growth and changing cell division modes.

Loss of Par3 promotes prostatic tumorigenesis by enhancing cell growth and changing cell division modes.

Journal: Oncogene

Published: April 02, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026